JP2015512441A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015512441A5 JP2015512441A5 JP2015504545A JP2015504545A JP2015512441A5 JP 2015512441 A5 JP2015512441 A5 JP 2015512441A5 JP 2015504545 A JP2015504545 A JP 2015504545A JP 2015504545 A JP2015504545 A JP 2015504545A JP 2015512441 A5 JP2015512441 A5 JP 2015512441A5
- Authority
- JP
- Japan
- Prior art keywords
- acrylic resin
- eudragit
- resin polymer
- composition
- immunological composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261686372P | 2012-04-04 | 2012-04-04 | |
| US61/686,372 | 2012-04-04 | ||
| PCT/US2013/000102 WO2013151595A1 (en) | 2012-04-04 | 2013-04-03 | Improved adjuvant system for oral vaccine adminstration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015512441A JP2015512441A (ja) | 2015-04-27 |
| JP2015512441A5 true JP2015512441A5 (enExample) | 2015-09-17 |
| JP6240155B2 JP6240155B2 (ja) | 2017-11-29 |
Family
ID=49300897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015504545A Expired - Fee Related JP6240155B2 (ja) | 2012-04-04 | 2013-04-03 | 経口ワクチン投与のための改善アジュバント系 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20150079130A1 (enExample) |
| EP (2) | EP3549605A1 (enExample) |
| JP (1) | JP6240155B2 (enExample) |
| KR (1) | KR101867428B1 (enExample) |
| AU (1) | AU2013243971B2 (enExample) |
| CA (1) | CA2903313C (enExample) |
| DK (1) | DK2833914T3 (enExample) |
| IL (1) | IL234937B (enExample) |
| MX (1) | MX364946B (enExample) |
| WO (1) | WO2013151595A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3107568B1 (en) * | 2014-02-20 | 2024-03-27 | Vaxart, Inc. | Formulations for small intestinal delivery |
| WO2015192216A1 (en) * | 2014-06-20 | 2015-12-23 | University Of Saskatchewan | Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis |
| KR102678401B1 (ko) | 2015-06-12 | 2024-06-26 | 박사르트, 인크. | Rsv 및 노로바이러스 항원들의 소장 내의 전달을 위한 제형들 |
| CA3016860A1 (en) * | 2016-03-07 | 2017-09-14 | Glaxosmithkline Biologicals Sa | Drug delivery particles |
| CA3097058A1 (en) * | 2018-04-16 | 2019-10-24 | Merck Patent Gmbh | Additives for protein formulations to improve thermal stability |
| KR102369740B1 (ko) | 2020-09-21 | 2022-03-02 | 부경대학교 산학협력단 | 자궁경부암 조기진단을 위한 모바일 질확대경 장치 |
| WO2022094816A1 (en) * | 2020-11-04 | 2022-05-12 | Janssen Pharmaceuticals, Inc. | Solid formulation |
| CN113750228B (zh) * | 2021-09-25 | 2024-02-20 | 大连理工大学 | 一种冷冻保护剂在铝佐剂中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4133397A (en) * | 1996-10-28 | 1998-05-22 | Pfizer Inc. | Oral vaccines for young animals with an enteric coating |
| WO1998035562A1 (en) * | 1997-02-14 | 1998-08-20 | Merck & Co., Inc. | Polynucleotide vaccine formulations |
| US7087235B2 (en) | 1997-06-25 | 2006-08-08 | The United States Of America As Represented By The Secretary Of The Army | Fusion protein of streptococcal pyrogenic exotoxins |
| US20030162955A1 (en) * | 1998-03-17 | 2003-08-28 | Lionel Chalus | Isolated mammalian membrane protein genes; related reagents |
| ES2260916T3 (es) * | 1998-07-08 | 2006-11-01 | Kirin-Amgen, Inc. | Preparacion en polvo para administracion a traves de la mucosa que contiene una medicina polimerica. |
| EP1046651A1 (en) * | 1999-04-19 | 2000-10-25 | Koninklijke Universiteit Nijmegen | Composition and method for modulating dendritic cell-T interaction |
| WO2004018698A2 (en) * | 2002-08-20 | 2004-03-04 | Genitrix, Llc | Lectin compositions and methods for modulating an immune response to an antigen |
| WO2004073652A2 (en) * | 2003-02-20 | 2004-09-02 | Becton Dickinson And Company | Powder formulations of recombinant staphylococcal enterotoxin b (rseb) made by atmospheric spray-freeze drying for improved vaccination |
| GB0505518D0 (en) * | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
| WO2008039432A1 (en) * | 2006-09-26 | 2008-04-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for enhancing an adjuvant |
| EP2464341B1 (en) * | 2009-08-12 | 2022-07-06 | Sublimity Therapeutics Limited | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
| GB0919690D0 (en) * | 2009-11-10 | 2009-12-23 | Guy S And St Thomas S Nhs Foun | compositions for immunising against staphylococcus aureus |
| GB201101665D0 (en) * | 2011-01-31 | 2011-03-16 | Novartis Ag | Immunogenic compositions |
-
2013
- 2013-04-03 MX MX2014011806A patent/MX364946B/es active IP Right Grant
- 2013-04-03 AU AU2013243971A patent/AU2013243971B2/en not_active Ceased
- 2013-04-03 CA CA2903313A patent/CA2903313C/en active Active
- 2013-04-03 WO PCT/US2013/000102 patent/WO2013151595A1/en not_active Ceased
- 2013-04-03 JP JP2015504545A patent/JP6240155B2/ja not_active Expired - Fee Related
- 2013-04-03 KR KR1020147030919A patent/KR101867428B1/ko not_active Expired - Fee Related
- 2013-04-03 EP EP19151134.4A patent/EP3549605A1/en not_active Withdrawn
- 2013-04-03 US US13/261,964 patent/US20150079130A1/en not_active Abandoned
- 2013-04-03 DK DK13772028.0T patent/DK2833914T3/en active
- 2013-04-03 EP EP13772028.0A patent/EP2833914B1/en active Active
-
2014
- 2014-10-02 IL IL234937A patent/IL234937B/en unknown
-
2018
- 2018-12-06 US US16/212,088 patent/US20190105389A1/en not_active Abandoned
-
2020
- 2020-11-05 US US17/090,292 patent/US20210052725A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2590479T3 (es) | Sistemas de administración de fármacos que comprenden fármacos débilmente básicos y ácidos orgánicos | |
| JP2017523180A5 (enExample) | ||
| ES2307044T3 (es) | Forma de medicamento multicapa que contiene una sustancia con actividad moduladora en lo que respeta a la liberacion del principio activo. | |
| KR101387835B1 (ko) | 코팅된 제약 제형을 제조하기 위한 중합체 혼합물의 용도및 혼합된 중합체성 코팅을 갖는 제약 제형 | |
| CN104302278B (zh) | 在回肠和阑尾上有活性的胃肠位点特异性口服接种疫苗制剂 | |
| Jain et al. | Expedition of Eudragit® polymers in the development of novel drug delivery systems | |
| JP2018521028A5 (enExample) | ||
| RU2016147009A (ru) | Композиции с пролонгированным высвобождением в виде суспензии | |
| ES2716550T3 (es) | Formulación farmacéutica o nutracéutica gastrorresistente que comprende una o más sales de ácido algínico | |
| HRP20230305T1 (hr) | Pripravci za ileo-jejunalnu dostavu lijeka | |
| KR20190028555A (ko) | 비강내 전달을 위한 방법 및 조성물 | |
| JP2009530298A5 (enExample) | ||
| JP2018533547A (ja) | ワクチン組成物 | |
| KR102381586B1 (ko) | 메살라진의 경구용 약제학적 조성물 | |
| JP2012097088A5 (enExample) | ||
| KR20080024200A (ko) | 감소된 ｐＨ 값에서 활성 성분을 방출하는 약제를 제조하기위한 코팅으로서의 부분 중화된음이온（메트）아크릴레이트 공중합체의 용도 | |
| JP2015519330A5 (enExample) | ||
| JP7041334B2 (ja) | 放出調節コーティングカプセル | |
| JP2021531345A5 (enExample) | ||
| WO2018072709A1 (zh) | 医药微丸的干粉包衣组合物 | |
| JP2020063290A (ja) | 放出調節コーティングカプセル | |
| DK2833914T3 (en) | ADMINISTRATIVE SYSTEM FOR ORAL VACCINE ADMINISTRATION | |
| Mangal et al. | Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system (s) administered intranasally | |
| JP2019534897A5 (enExample) | ||
| CN1972674B (zh) | 多层形式的药物 |